EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cutting-edge nanobiosensors: Revolutionizing cancer diagnosis and enabling precision medicine

Mahbod Fazlali, Maedeh Nasira, Mahmoud Osanloo, Elham Zarenezhad

Clinica Chimica Acta · 2026

DOI: 10.1016/j.cca.2025.120613 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinica Chimica Acta, 2026. Verfasst von Mahbod Fazlali und 3 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran; Noncommunicable Diseases Research Center, Fasa University of Medical Sci…. Hauptthemen laut MEDLINE: Biosensing Techniques, Precision Medicine, Neoplasms, Nanotechnology. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 175 Literaturangaben. Gefördert von: Fasa University of Medical Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Integrating nanotechnology and artificial intelligence (AI) revolutionizes cancer diagnostics, propelling precision medicine into a transformative era. This review examines state-of-the-art nanobiosensors capable of detecting critical biomarkers-circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and microRNAs (miRNAs), with unprecedented sensitivity and specificity. We comprehensively analyze four primary biosensor modalities: optical, electrochemical, magnetic, and piezoelectric systems. These technologies facilitate early cancer detection, real-time disease monitoring, liquid biopsies, and theranostic applications. AI augments sensor performance by refining device design, optimizing signal processing, and enabling seamless integration within clinical workflows. Innovations in nanomaterials-from carbon-based nanoparticles (NPs) and metallic frameworks to polymeric and hybrid composites-underpin multifunctional platforms that merge molecular recognition, imaging, and therapeutic functionalities. RNA-targeting advancements, including single-cell sequencing and epitranscriptomic detection, further expand diagnostic frontiers by revealing novel biomarker signatures. Despite these advances, significant challenges remain in scalable manufacturing, long-term stability, regulatory compliance, and environmental sustainability. We advocate the development of portable, AI-driven point-of-care platforms and eco-friendly manufacturing practices to democratize access to these technologies globally. Through earlier detection, tailored treatment strategies, and equitable distribution, nanobiosensors are poised to redefine oncology diagnostics and improve patient outcomes worldwide, impacting clinical decision-making and patient quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesPrecision MedicineNeoplasmsNanotechnologyHumansBiomarkers, Tumor

Stichwörter der Autor:innen

AI-driven diagnosticsLiquid biopsyNanobiosensorsPrecision oncologySustainable nanotechnology

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran; Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
  • Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa, Iran.
  • Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran. Electronic address: El.zarenezhad@fums.ac.ir.

Förderung

  • Fasa University of Medical Science

Zitieren

APA

Fazlali, M., Nasira, M., Osanloo, M., & Zarenezhad, E. (2026). Cutting-edge nanobiosensors: Revolutionizing cancer diagnosis and enabling precision medicine. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2025.120613

Vancouver

Fazlali M, Nasira M, Osanloo M, Zarenezhad E. Cutting-edge nanobiosensors: Revolutionizing cancer diagnosis and enabling precision medicine. Clinica Chimica Acta. 2026. doi:10.1016/j.cca.2025.120613

BibTeX
@article{Fazlali2026,
  author = {Fazlali, Mahbod and Nasira, Maedeh and Osanloo, Mahmoud and Zarenezhad, Elham},
  title = {Cutting-edge nanobiosensors: Revolutionizing cancer diagnosis and enabling precision medicine},
  journal = {Clinica Chimica Acta},
  year = {2026},
  doi = {10.1016/j.cca.2025.120613}
}
Kostenlos starten →